Cognizant providers will present automation and digital applied sciences that may scale back value of service and velocity time to market
TEANECK, N.J., March 25, 2024 /PRNewswire/ — Cognizant (NASDAQ: CTSH) introduced as we speak it has been chosen by Clario, a healthcare analysis know-how firm that delivers main endpoint know-how options for scientific trials, to assist its international IT infrastructure and purposes. The collaboration will assist Clario advance its worker and buyer choices in assist of its mission to rework lives by producing high-quality proof for extra knowledgeable resolution making.
“At Clario, we delight ourselves on offering the perfect know-how for our prospects and we do this by creating a sturdy and progressive ecosystem,” stated Jay Ferro, EVP, Chief Data, Expertise & Product Officer at Clario. “Cognizant’s progressive know-how and business experience made them the pure option to associate on the following part of our digital transformation journey.”
Clario develops digital options that redefine potentialities in scientific trials by enhancing the accuracy, reliability, velocity, and effectivity of information gathering and evaluation. Over the course of the five-year relationship, Clario will leverage Cognizant’s expertise in automation and digital applied sciences for course of and expertise modernization, supporting:
- Attaining sooner time to market by streamlining workflows and enhancing collaboration throughout groups.
- Constructing a basis for a digital enterprise by integrating information, analytics, and AI capabilities throughout the corporate.
- Driving leading edge innovation within the scientific trials area by adopting agile methodologies and finest practices.
“Medical trials require safe and dependable know-how to handle affected person information, monitor outcomes, guarantee rules are met, and extra.” stated Cognizant’s Mohammad Haque, SVP, World Giant Offers Lead and BU Head, Life Sciences. “Clario is doing groundbreaking work in offering this know-how to run scientific trials, and Cognizant is happy to work alongside them to modernize their choices.”
About Cognizant
Cognizant (Nasdaq: CTSH) engineers fashionable companies. We assist our shoppers modernize know-how, reimagine processes and remodel experiences to allow them to keep forward in our fast-changing world. Collectively, we’re enhancing on a regular basis life. See how at www.cognizant.com or @cognizant.
About Clario
Clario is a number one healthcare analysis and know-how firm that generates the very best high quality scientific proof for pharmaceutical, biotech, and medical gadget companions. They provide complete proof technology options that mix eCOA, cardiac security, medical imaging, precision movement, and respiratory endpoints.
Clario’s international workforce of science, know-how, and operational consultants have helped ship over 26,000 trials and contributed to over 800 regulatory approvals in additional than 100 international locations. For greater than 50 years, they’ve delivered deep scientific experience and probably the most complete endpoint applied sciences to assist remodel lives world wide.
View authentic content material to obtain multimedia: https://www.prnewswire.com/news-releases/clario-selects-cognizant-as-global-strategic-technology-services-provider-to-optimize-and-advance-their-clinical-transformation-journey-302097723.html
SOURCE Cognizant Expertise Options Company